Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor

British Journal of Cancer

Volumn 76, Issue 1, 1997, Pages 83-89

  Suzuki, S ^a   Inoue, K ^a   Hongoh, A ^a   Hashimoto, Y ^a   Yamazoe, Y ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Cancer chemotherapy; Doxorubicin; Endocytosis; Immunoliposomes; Multidrug resistance; Transferrin receptor

Indexed keywords

CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; DOXORUBICIN; IMMUNOLIPOSOME; MONOCLONAL ANTIBODY; PHOSPHATIDYLETHANOLAMINE; RECEPTOR ANTIBODY; TRANSFERRIN RECEPTOR;

ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG TARGETING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0030983406     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.340     Document Type: Article

References (29)

1. Aisenberg AC and Wilkes BM (1980) Unusual human lymphoma phenotype defined by monoclonal antibody. J Exp Med 152: 1126-1131
2. Berinstein N, Matthay KK, Papahadjopoulos D, Levy R and Sikic BI (1987) Antibody-directed targeting of liposomes to human cell lines: role of binding and internalization on growth inhibition. Cancer Res 47: 5954-5949
3. Carlsson J, Drevin H and Axen R (1978) Protein thiolation and reversible protein protein conjugation. N-succinimidyl 3-(2-pyridyldithio)propionate. a new heterobifunctional reagent. Biochem J 173: 723-737
4. Collins D, Maxfield F and Huang L (1989) Immunoliposomes with different acid sensitivities as probes for the cellular endocytic pathway. Biochim Biophys Acta 987: 47-55
5. Esserman L, Takahashi S, Rojas V, Warnke R and Levy R (1989) An epitope of the transferrin receptor is exposed on the cell surface of high-grade but not low-grade human lymphomas. Blood 74: 2718-2729
6. Gervasoni JE, Fields SZF, Krishna S, Baker MA, Rosado M, Thuraisamy K, Hindenburg AA and Taub RN (1991). Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laserassisted confocal microscopy. Cancer Res 51: 4955-4963
7. Girones N and Davis RJ (1989) Comparison of the kinetics of cycling of the transferrin receptor in the presence or absence of bound diferric transferrin. Biochem J 264: 35-46.
8. Gros P, Neriah YB, Croop JM and Housman DE (1986) Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323: 728-731
9. Hamilton TA, Wada HG and Sussman HH (1979) Identification of transferrin receptors on the surface of human cultured cells. Proc Natl Acad Sci USA 76: 6406-6411
10. Harris AL and Hochhauser D (1992) Mechanisms of multidrug resistance in cancer treatment. Acta Oncol 31: 205-213
11. Hashimoto Y, Sugawara M and Endoh H (1983) Coating of liposomes with subunits of monoclonal IgM antibody and targeting of the liposomes. J Immunol Methods 62: 155-162
12. Hindenburg AA, Gervasoni JE, Krishna S, Stewart VJ, Rosado M, Lutzky J, Bhalla K, Baker MA and Taub RN (1989) Intracellular distribution and pharmacokinetics of daunomycin in anthracyclin-sensitive and -resistant HL60 cells. Cancer Res 49: 4607-4614
13. Lasic DD, Frederik PM, Stuart MCA, Barenholz Y and MeIntosh TJ (1992) Gelation of liposome interior a novel method for drug encapsulation. FEBS Lett 312: 255-258
14. Marquardt D and Center MS (1992) Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cells. Cancer Res 52: 3157-3163
15. Masuko T, Sugahara K, Kozono M and 5 others (1989) A murine monoclonal antibody that recognizes an extracellular domain of the human c-erbB-2 protooncogene product. Jpn J Cancer Res 80: 10-14
16. Matthay KK, Abai AM, Cobb S, Hong K, Papahadjopoulos D and Straubinger RM (1989) Role of ligand in antibody-directed endocytosis of liposomes by human T-leukemia cells. Cancer Res 49: 4879-4986
17. Sadasivan R, Morgan R, Fabian C and Stephens R (1991) Reversal of multidrug resistance in HL-60 cells by verapamil and liposome-encapsulated doxorubicin. Cancer Lett 57: 165-171
18. Suzuki S, Masuko T, Takanashi K, Takashio K and Hashinioto Y (1992) Assay of cell surface-bound immunoliposomes using monoclonal antibody reacts with a crosslinking reagent. Chem Pharm Bull 40: 1893-1896
19. Suzuki S, Watanabe S, Uno S, Tanaka M, Masuko T and Hashimoto Y (1994) Endocytosis does not necessarily augment the cytotoxicity of adriamycin encapsulated in immunoliposomes. Biochim Biophys Acta 1224: 445-453
20. Suzuki S, Uno S, Fukuda Y, Aoki Y, Masuko T and Hashimoto Y (1995a) Cytotoxicity of anti-c-erbB-2 immunoliposomes containing adriamycin on human cancer cells. Br J Cancer 72: 663-668
21. Suzuki S, Watanabe S, Masuko T and Hashimoto Y (1995b) Preparation of long-circulating immunoliposomes containing adriamycin by a novel method to coat immunoliposomes with poly(ethylene glycol). Biochim Biophys Acta 1245: 9-16
22. Tanaka T, Suzuki S, Masuko T and Hashimoto Y (1989) In vitro targeting and cytotoxicity of adriamycin in liposomes bearing monoclonal antibody against rat or human gp125 cell proliferation-associated antigen. Jpn J Cancer Res 80: 380-386
23. Thierry AR, Vige D, Coughlin SS, Belli JA, Dritschilo A and Rahman A (1993) Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes. FASEB J 7: 572-529
24. Trowbridge IS and Omary MB (1981) Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin Proc Natl Acad Sci USA 75: 3039-3043
25. Tsuruo T, Iida H, Tsukagoshi S and Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41: 1967-1972
26. Tsuruo T, Iida H, Tsukagoshi S and Sakurai Y (1982) Increased accumulation of vincristine and adriamycin in drug-resistant P 388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res 42: 4730-4733
27. Tsuruo T, Iida Saito H, Kawabata H, Ohhara T, Hamada H and Utakoji T (1986) Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones. Jpn J Cancer Res 77: 682-692
28. Weissman AM, Klausner RD, Rao K and Harford JB (1986) Exposure of K562 cells to anti-receptor monoclonal antibody OKT9 results in rapid redistribution and enhanced degradation of the transferrin receptor. J Cell Biol 102: 951-958
29. Willingham MC, Cornwell MM, Cardarelli CO, Gottesman MM and Pastan I (1986) Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs. Cancer Res 46: 5941-5946